Literature DB >> 1274529

In vitro characteristics of a sacrococcygeal chordoma maintained in tissue and organ culture systems.

B C Horten, S R Montague.   

Abstract

Explants of a human sacral chordoma were successfully maintained on collagen-coated coverslips, gelfoam sponge matrices, and Millipore filter platforms for up to 30 days. Tumor cells cultured on collagen-coated coverslips became increasingly vacuolated whereas those maintained in organ culture were entirely free of vacuoles after 22 days in vitro. A single basic tumor cell, small and polygonal with a large central spherical nucleus and abundant endoplasmic reticulum and Golgi apparatus, was recognized. Vacuoles were formed as the result of the progressive expansion of smooth endoplasmic reticulum. Coalescence of these vacuoles produced the physaliferous cell of light microscopy.

Entities:  

Mesh:

Year:  1976        PMID: 1274529     DOI: 10.1007/BF00688940

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  19 in total

1.  CHORDOMA: AN ELECTRON MICROSCOPIC STUDY.

Authors:  H J SPJUT; S A LUSE
Journal:  Cancer       Date:  1964-05       Impact factor: 6.860

2.  FINE STRUCTURE OF A RECURRENT CHORDOMA.

Authors:  P CANCILLA; R MORECKI; E S HURWITT
Journal:  Arch Neurol       Date:  1964-09

3.  The fine structure of chordoma with particular reference to the physaliphorous cell.

Authors:  I FRIEDMANN; D F HARRISON; E S BIRD
Journal:  J Clin Pathol       Date:  1962-03       Impact factor: 3.411

4.  Chordoma.

Authors:  D C DAHLIN; C S MACCARTY
Journal:  Cancer       Date:  1952-11       Impact factor: 6.860

5.  [Electron microscopic characteristics of caudal chordoma].

Authors:  V G Pinchuk; V S Svigun; B D Monastyrskaia
Journal:  Arkh Patol       Date:  1969

6.  Ultrastructure of human chordoma.

Authors:  R A Erlandson; B Tandler; P H Lieberman; N L Higinbotham
Journal:  Cancer Res       Date:  1968-10       Impact factor: 12.701

7.  Ultrastructure of a chordoma.

Authors:  T M Murad; M S Murthy
Journal:  Cancer       Date:  1970-05       Impact factor: 6.860

8.  [Ultrastructure of human chordomas].

Authors:  D Soffer; J M Brucher; W Wechsler
Journal:  Pathol Eur       Date:  1970

9.  [Ultrastructural study of a sacral chordoma].

Authors:  J P Cesarini; H Bonneau
Journal:  Arch Anat Pathol (Paris)       Date:  1971-03

10.  [Ultrastructural study of a chordoma].

Authors:  M F Tripler; J Hassoun; M Toga
Journal:  J Neurol Sci       Date:  1975-07       Impact factor: 3.181

View more
  9 in total

1.  Generation of chordoma cell line JHC7 and the identification of Brachyury as a novel molecular target.

Authors:  Wesley Hsu; Ahmed Mohyeldin; Sagar R Shah; Colette M ap Rhys; Lakesha F Johnson; Neda I Sedora-Roman; Thomas A Kosztowski; Ola A Awad; Edward F McCarthy; David M Loeb; Jean-Paul Wolinsky; Ziya L Gokaslan; Alfredo Quiñones-Hinojosa
Journal:  J Neurosurg       Date:  2011-06-24       Impact factor: 5.115

2.  Surgical Outcomes of Clival Chordoma Through Endoscopic Endonasal Approach: A Single-Center Experience.

Authors:  Ge Chen; Mingchu Li; Wenlong Xu; Xu Wang; Ming Feng; Renzhi Wang; Xiaohai Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-06       Impact factor: 6.055

3.  Clinical features and prognostic factors of patients with chordoma in the spine: a retrospective analysis of 153 patients in a single center.

Authors:  Tong Meng; Huabin Yin; Bo Li; Zhenxi Li; Wei Xu; Wang Zhou; Mo Cheng; Jing Wang; Lei Zhou; Xinghai Yang; Tielong Liu; Wangjun Yan; Dianwen Song; Jianru Xiao
Journal:  Neuro Oncol       Date:  2014-12-08       Impact factor: 12.300

4.  Human ecchordosis physaliphora and chick embryonic notochord. A comparative electron microscopic study.

Authors:  B C Horten; S R Montague
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-10-07

5.  Visualization of cellular aggregates cultured on a three dimensional collagen sponge matrix.

Authors:  W H Douglas; J A McAteer; R T Dell'orco; D Phelps
Journal:  In Vitro       Date:  1980-04

6.  Prognostic significance of pretreatment plasma D-dimer levels in patients with spinal chordoma: a retrospective cohort study.

Authors:  Bo Li; Hao Zhang; Pingting Zhou; Jiaxiang Yang; Haifeng Wei; Xinghai Yang; Cheng Yang; Zhipeng Wu; Jianru Xiao
Journal:  Eur Spine J       Date:  2019-01-25       Impact factor: 3.134

7.  Molecular characterization of putative chordoma cell lines.

Authors:  Silke Brüderlein; Joshua B Sommer; Paul S Meltzer; Sufeng Li; Takuya Osada; David Ng; Peter Möller; David A Alcorta; Michael J Kelley
Journal:  Sarcoma       Date:  2010-12-30

8.  Resolving tumor heterogeneity: genes involved in chordoma cell development identified by low-template analysis of morphologically distinct cells.

Authors:  Amin El-Heliebi; Thomas Kroneis; Karin Wagner; Katharina Meditz; Dagmar Kolb; Julia Feichtinger; Gerhard G Thallinger; Franz Quehenberger; Bernadette Liegl-Atzwanger; Beate Rinner
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

9.  Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft.

Authors:  Thibault Passeri; Ahmed Dahmani; Julien Masliah-Planchon; Adnan Naguez; Marine Michou; Rania El Botty; Sophie Vacher; Rachida Bouarich; André Nicolas; Marc Polivka; Coralie Franck; Anne Schnitzler; Fariba Némati; Sergio Roman-Roman; Franck Bourdeaut; Homa Adle-Biassette; Hamid Mammar; Sébastien Froelich; Ivan Bièche; Didier Decaudin
Journal:  Cancers (Basel)       Date:  2022-03-14       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.